The FDA has approved the use and administration of a promising new medication for treating Congenital Adrenal Hyperplasia.
Within the next several months, local mice and rats will begin to self-administer the new drug, at the reccomendation of their doctors following the approval.
Doctors and patients remain hopeful, but express concerns about pricing and delivery methods.
"I'm afraid to stab myself with a needle. I'm already an ill person", reported one patient.
Many, however, are prepared to bite the bullet. The promise of the beneifts of a steroid with none of the downside, for a cost.
This is a developing story.
